UTMD
UTMD
NASDAQ · Health Care

Utah Medical Products Inc

$61.54
-1.06 (-1.69%)
As of Mar 29, 10:35 PM ET ·
Financial Highlights (FY 2026)
Revenue
36.74M
Net Income
12.46M
Gross Margin
59.0%
Profit Margin
33.9%
Rev Growth
-5.9%
D/E Ratio
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 59.0% 59.0% 48.9% 48.9%
Operating Margin 33.2% 29.9% 11.5% 10.7%
Profit Margin 33.9% 32.2% 10.8% 9.8%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 36.74M 39.03M 91.03M 78.58M
Gross Profit 21.69M 23.04M 44.52M 38.43M
Operating Income 12.21M 11.67M 10.51M 8.39M
Net Income 12.46M 11.92M 9.79M 7.70M
Gross Margin 59.0% 59.0% 48.9% 48.9%
Operating Margin 33.2% 29.9% 11.5% 10.7%
Profit Margin 33.9% 32.2% 10.8% 9.8%
Rev Growth -5.9% -5.9% +19.7% +6.6%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 56.05M 53.25M
Total Equity 101.18M 111.70M
D/E Ratio 0.55 0.48
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA 13.89M 14.02M 14.55M 11.68M
Free Cash Flow 8.08M 6.39M